OMV Aktiengesellschaft (ETR:OMV)

Verve Therapeutics Statistics

Total Valuation

ETR:OMV has a market cap or net worth of EUR 14.46 billion. The enterprise value is 22.02 billion.

Market Cap	14.46B
Enterprise Value	22.02B

Important Dates

The last earnings date was Thursday, July 31, 2025.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	Jun 4, 2025

Share Statistics

Current Share Class	327.00M
Shares Outstanding	n/a
Shares Change (YoY)	+0.41%
Shares Change (QoQ)	-0.72%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	142.06M

Valuation Ratios

The trailing PE ratio is 15.60 and the forward PE ratio is 8.15.

PE Ratio	15.60
Forward PE	8.15
PS Ratio	0.45
PB Ratio	0.63
P/TBV Ratio	0.94
P/FCF Ratio	13.44
P/OCF Ratio	2.96
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.24, with an EV/FCF ratio of 20.46.

EV / Earnings	23.75
EV / Sales	0.68
EV / EBITDA	3.24
EV / EBIT	4.85
EV / FCF	20.46

Financial Position

The company has a current ratio of 2.10, with a Debt / Equity ratio of 0.33.

Current Ratio	2.10
Quick Ratio	0.79
Debt / Equity	0.33
Debt / EBITDA	1.14
Debt / FCF	7.01
Interest Coverage	11.20

Financial Efficiency

Return on equity (ROE) is 5.76% and return on invested capital (ROIC) is 8.59%.

Return on Equity (ROE)	5.76%
Return on Assets (ROA)	5.81%
Return on Invested Capital (ROIC)	8.59%
Return on Capital Employed (ROCE)	12.31%
Revenue Per Employee	1.41M
Profits Per Employee	40,459
Employee Count	23,557
Asset Turnover	0.69
Inventory Turnover	7.88

Taxes

In the past 12 months, ETR:OMV has paid 2.23 billion in taxes.

Income Tax	2.23B
Effective Tax Rate	62.07%

Stock Price Statistics

The stock price has increased by +18.46% in the last 52 weeks. The beta is 0.97, so ETR:OMV's price volatility has been similar to the market average.

Beta (5Y)	0.97
52-Week Price Change	+18.46%
50-Day Moving Average	45.82
200-Day Moving Average	42.36
Relative Strength Index (RSI)	41.88
Average Volume (20 Days)	14,310

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ETR:OMV had revenue of EUR 32.33 billion and earned 927.00 million in profits. Earnings per share was 2.82.

Revenue	32.33B
Gross Profit	9.01B
Operating Income	4.37B
Pretax Income	3.59B
Net Income	927.00M
EBITDA	6.40B
EBIT	4.37B
Earnings Per Share (EPS)	2.82

Balance Sheet

The company has 6.39 billion in cash and 7.54 billion in debt, giving a net cash position of -1.15 billion.

Cash & Cash Equivalents	6.39B
Total Debt	7.54B
Net Cash	-1.15B
Net Cash Per Share	n/a
Equity (Book Value)	22.89B
Book Value Per Share	42.05
Working Capital	11.52B

Cash Flow

In the last 12 months, operating cash flow was 4.89 billion and capital expenditures -3.82 billion, giving a free cash flow of 1.08 billion.

Operating Cash Flow	4.89B
Capital Expenditures	-3.82B
Free Cash Flow	1.08B
FCF Per Share	n/a

Margins

Gross margin is 27.87%, with operating and profit margins of 13.51% and 3.06%.

Gross Margin	27.87%
Operating Margin	13.51%
Pretax Margin	11.11%
Profit Margin	3.06%
EBITDA Margin	19.80%
EBIT Margin	13.51%
FCF Margin	3.33%

Dividends & Yields

This stock pays an annual dividend of 4.75, which amounts to a dividend yield of 10.72%.

Dividend Per Share	4.75
Dividend Yield	10.72%
Dividend Growth (YoY)	-5.94%
Years of Dividend Growth	n/a
Payout Ratio	91.79%
Buyback Yield	-0.41%
Shareholder Yield	10.32%
Earnings Yield	6.41%
FCF Yield	7.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ETR:OMV has an Altman Z-Score of 2.07 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.07
Piotroski F-Score	7